{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:09:24Z","timestamp":1789427364013,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.06.097","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T08:46:55Z","timestamp":1216457215000},"page":"4830-4839","source":"Crossref","is-referenced-by-count":7,"title":["Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors"],"prefix":"10.1016","volume":"26","author":[{"given":"M.","family":"Aidoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Bile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Nkengasong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"McNicholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.06.097_bib1","unstructured":"UNAIDS. AIDS Epidemic Update. Geneva, Switzerland; 2003."},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.097_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(02)00343-2","article-title":"Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy","volume":"2","author":"Thomson","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.097_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/088922203322280892","article-title":"New HIV type 1 CRF01_AE\/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand","volume":"19","author":"Ramos","year":"2003","journal-title":"AIDS Res Hum Retrov"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.097_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/viro.2002.1577","article-title":"Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development","volume":"302","author":"Ellenberger","year":"2002","journal-title":"Virology"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2008.06.097_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/vir.0.19396-0","article-title":"Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice","volume":"85","author":"Jaffray","year":"2004","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.097_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1086\/376506","article-title":"Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults","volume":"188","author":"Pitisuttithum","year":"2003","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2008.06.097_bib7","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.1073\/pnas.162006499","article-title":"MHC heterozygosity confers a selective advantage against multiple-strain infections","volume":"99","author":"Penn","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.097_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0952-7915(98)80124-6","article-title":"HLA supertypes and supermotifs: a functional perspective on HLA polymorphism","volume":"10","author":"Sette","year":"1998","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.097_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ni806","article-title":"T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens","volume":"3","author":"Brehm","year":"2002","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.097_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/intimm\/13.7.941","article-title":"The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes","volume":"13","author":"Buseyne","year":"2001","journal-title":"Int Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.06.097_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1084\/jem.190.9.1319","article-title":"Selective expansion of cross-reactive CD8(+) memory T cells by viral variants","volume":"190","author":"Haanen","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.06.097_bib12","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1126\/science.283.5408.1748","article-title":"HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage","volume":"283","author":"Carrington","year":"1999","journal-title":"Science"},{"issue":"6869","key":"10.1016\/j.vaccine.2008.06.097_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/415335a","article-title":"Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes","volume":"415","author":"Barouch","year":"2002","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.097_bib14","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L","article-title":"T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection","volume":"30","author":"Maini","year":"2000","journal-title":"Eur J Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2008.06.097_bib15","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1128\/JVI.76.18.9011-9023.2002","article-title":"A balanced type 1\/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection","volume":"76","author":"Imami","year":"2002","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.097_bib16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.097_bib17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1086\/382028","article-title":"HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load","volume":"189","author":"Oxenius","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.097_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1086\/315764","article-title":"Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease","volume":"182","author":"Wilson","year":"2000","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2008.06.097_bib19","doi-asserted-by":"crossref","first-page":"12430","DOI":"10.1128\/JVI.77.23.12430-12440.2003","article-title":"Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual","volume":"77","author":"Geels","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.097_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2003.10.013","article-title":"Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms","volume":"319","author":"Ellenberger","year":"2004","journal-title":"Virology"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2008.06.097_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2005.06.014","article-title":"Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA\/MVA vaccines expressing mature and immature VLPs","volume":"340","author":"Ellenberger","year":"2005","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.097_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virol.2006.04.005","article-title":"HIV-1 DNA\/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges","volume":"352","author":"Ellenberger","year":"2006","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.vaccine.2008.06.097_bib23","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/00002030-200209060-00015","article-title":"Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants","volume":"16","author":"Dowling","year":"2002","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.097_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002030-199901140-00015","article-title":"Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Cote d\u2019Ivoire","volume":"13","author":"Nkengasong","year":"1999","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.097_bib25","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/JVI.77.3.2081-2092.2003","article-title":"Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load","volume":"77","author":"Addo","year":"2003","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.097_bib26","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/JVI.76.10.4971-4986.2002","article-title":"Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles","volume":"76","author":"Currier","year":"2002","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.097_bib27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/aid.1994.10.1359","volume":"10","author":"Gao","year":"1994","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.vaccine.2008.06.097_bib28","series-title":"Human retroviruses and AIDS","first-page":"III15","article-title":"Sequencing primers for HIV-1","author":"Sanders-Buell","year":"1995"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.097_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/08892220150503726","article-title":"Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo","volume":"17","author":"Yang","year":"2001","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.vaccine.2008.06.097_bib30","series-title":"Human retroviruses and AIDS","article-title":"Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic","author":"Carr","year":"1998"},{"issue":"22","key":"10.1016\/j.vaccine.2008.06.097_bib31","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2008.06.097_bib32","unstructured":"Hall T. BioEdit: a user-friendly biological sequence alignment editor and analyses program for windows96\/98\/NT. Nucleic Acids Symposium No. 41; 1999. p. 95\u20138."},{"key":"10.1016\/j.vaccine.2008.06.097_bib33","first-page":"164","article-title":"PHYLIP\u2014phylogeny interference package","author":"Felsenstein","year":"1989","journal-title":"Cladistics"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.097_bib34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/466525","article-title":"Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d\u2019Ivoire","volume":"192","author":"Chahroudi","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.097_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1399-0039.2001.057004339.x","article-title":"HLA-B allele frequencies in Cote d\u2019Ivoire defined by direct DNA sequencing: identification of HLA-B*1405, B*4410, and B*5302","volume":"57","author":"Ellis","year":"2001","journal-title":"Tissue Antigens"},{"issue":"15","key":"10.1016\/j.vaccine.2008.06.097_bib36","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00002030-200310170-00002","article-title":"Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans","volume":"17","author":"Currier","year":"2003","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.097_bib37","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/00002030-200205030-00002","article-title":"Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57","volume":"16","author":"Gillespie","year":"2002","journal-title":"AIDS"},{"issue":"14","key":"10.1016\/j.vaccine.2008.06.097_bib38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1089\/08892220260235425","article-title":"Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays","volume":"18","author":"Keating","year":"2002","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.vaccine.2008.06.097_bib39","series-title":"HIV immunology and HIV\/SIV vaccine database","author":"Korber","year":"2003"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.097_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.193.3.375","article-title":"Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses","volume":"193","author":"Kelleher","year":"2001","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.vaccine.2008.06.097_bib41","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution","volume":"79","author":"Allen","year":"2005","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.097_bib42","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/JVI.78.5.2187-2200.2004","article-title":"Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities","volume":"78","author":"Frahm","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.097_bib43","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1128\/JVI.80.4.1949-1958.2006","article-title":"Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques","volume":"80","author":"Kawada","year":"2006","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2008.06.097_bib44","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1128\/JVI.01277-07","article-title":"Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape","volume":"81","author":"Liu","year":"2007","journal-title":"J Virol"},{"issue":"5514","key":"10.1016\/j.vaccine.2008.06.097_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1058915","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.097_bib46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/088922203322493067","article-title":"Gp120-alum boosting of a Gag\u2013Pol\u2013Env DNA\/MVA AIDS vaccine: poorer control of a pathogenic viral challenge","volume":"19","author":"Buge","year":"2003","journal-title":"AIDS Res Hum Retrov"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.097_bib47","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.vaccine.2007.12.024","article-title":"Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.097_bib48","doi-asserted-by":"crossref","first-page":"e725","DOI":"10.1371\/journal.pone.0000725","article-title":"Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial","volume":"2","author":"Launay","year":"2007","journal-title":"PLoS ONE"},{"issue":"20","key":"10.1016\/j.vaccine.2008.06.097_bib49","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1016\/j.vaccine.2007.02.050","article-title":"Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine","volume":"25","author":"Catanzaro","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800861X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0800861X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T20:01:19Z","timestamp":1557691279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0800861X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":49,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X0800861X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}